Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$342M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$300M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$270M |
| 4 |
Baker Hughes
BKR
|
+$249M |
| 5 |
Meta Platforms (Facebook)
META
|
+$220M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$650M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$424M |
| 3 |
Union Pacific
UNP
|
+$350M |
| 4 |
HES
Hess
HES
|
+$314M |
| 5 |
Deere & Co
DE
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.59% |
| 2 | Consumer Discretionary | 8.82% |
| 3 | Industrials | 8.12% |
| 4 | Financials | 7.95% |
| 5 | Healthcare | 5.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Peapack-Gladstone Financial
PGC
$804M
| $259K | ﹤0.01% |
+10,646
| New | +$272K |
|
2277
Acumen Pharmaceuticals
ABOS
$223M
| $259K | ﹤0.01% |
63,949
+43,371
| +211% | +$163K |
|
2278
Lufax Holding
LU
$1.17B
| $257K | ﹤0.01% |
60,808
-239,192
| -80% | -$670K |
|
2279
BOK Financial
BOKF
$8.54B
| $256K | ﹤0.01% |
2,780
-14,741
| -84% | -$1.25M |
|
2280
Palantir
PLTR
$423B
| $256K | ﹤0.01% |
+11,113
| New | +$237K |
|
2281
CALL
Upstart Holdings
UPST
$2.91B
| $255K | ﹤0.01% |
+9,500
| New | +$281K |
|
2282
Cabaletta Bio
CABA
$526M
| $255K | ﹤0.01% |
+14,963
| New | +$321K |
|
2283
Hamilton Beach Brands
HBB
$450M
| $254K | ﹤0.01% |
10,415
-10,275
| -50% | -$199K |
|
2284
Equinox Gold
EQX
$16.1B
| $253K | ﹤0.01% |
+41,965
| New | +$195K |
|
|
ACCD
2285
DELISTED
Accolade Inc
ACCD
| $252K | ﹤0.01% |
24,025
-905,931
| -97% | -$10.3M |
|
2286
Mirum Pharmaceuticals
MIRM
$5.9B
| $252K | ﹤0.01% |
+10,016
| New | +$275K |
|
2287
Medallion Financial
MFIN
$267M
| $251K | ﹤0.01% |
31,768
-21,677
| -41% | -$195K |
|
2288
Western New England Bancorp
WNEB
$278M
| $251K | ﹤0.01% |
32,698
-18,350
| -36% | -$152K |
|
2289
CRA International
CRAI
$1.1B
| $249K | ﹤0.01% |
+1,664
| New | +$197K |
|
2290
Jasper Therapeutics
JSPR
$24M
| $247K | ﹤0.01% |
+8,417
| New | +$150K |
|
2291
OceanFirst Financial
OCFC
$1.83B
| $247K | ﹤0.01% |
+15,027
| New | +$242K |
|
|
SWN
2292
DELISTED
Southwestern Energy Company
SWN
| $246K | ﹤0.01% |
32,519
-3,965
| -11% | -$26.9K |
|
2293
Metallus
MTUS
$776M
| $245K | ﹤0.01% |
+11,023
| New | +$230K |
|
2294
Rush Street Interactive
RSI
$3.05B
| $245K | ﹤0.01% |
37,669
-263,567
| -87% | -$1.42M |
|
2295
CorVel
CRVL
$3.6B
| $245K | ﹤0.01% |
2,793
-10,038
| -78% | -$807K |
|
2296
Gyre Therapeutics
GYRE
$683M
| $244K | ﹤0.01% |
+13,979
| New | +$252K |
|
2297
HSBC
HSBC
$357B
| $244K | ﹤0.01% |
6,206
-59,019
| -90% | -$2.3M |
|
2298
Blue Bird Corp
BLBD
$1.87B
| $242K | ﹤0.01% |
+6,311
| New | +$193K |
|
2299
Everspin Technologies
MRAM
$393M
| $242K | ﹤0.01% |
30,524
-17,777
| -37% | -$152K |
|
2300
Johnson Outdoors
JOUT
$491M
| $241K | ﹤0.01% |
+5,236
| New | +$241K |
|
Similar funds
Dmitry Balyasny's Q1 2024 Portfolio in Review
As of Q1 2024, Dmitry Balyasny held 3,271 positions worth $57.2B, up 7.5% from $53.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dmitry Balyasny's Q1 2024 filing shows 835 new, 795 increased, 814 reduced and 718 closed positions. Its largest new stake was Public Service Enterprise Group: 2,419,537 shares worth $162M. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $650M.
By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 9.2% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Dmitry Balyasny's largest Q1 2024 buy was Public Service Enterprise Group: 2,419,537 shares worth $162M.
- Dmitry Balyasny added most to Broadcom in Q1 2024, an estimated $342M increase.
- Dmitry Balyasny's biggest Q1 2024 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $650M.
- Dmitry Balyasny fully exited Splunk Inc in Q1 2024, selling an estimated $263M.
- Dmitry Balyasny's ten largest holdings make up 12% of its $57.2B portfolio in Q1 2024.
- Dmitry Balyasny opened 835 new positions and closed 718 in Q1 2024.
- Dmitry Balyasny's portfolio value rose 7.5% quarter-over-quarter to $57.2B.
Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.